Status:
COMPLETED
EHR-Embedded Decision Support to Prevent Stroke in Patients With AF
Lead Sponsor:
University of Cincinnati
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background and Significance - Atrial fibrillation (AF) is the most common significant cardiac rhythm disorder and is a powerful common risk factor for stroke. Randomized trials have demonstrated that ...
Detailed Description
C.2.1 Specific Aim 1 - Randomized Comparative Effectiveness Study to Evaluate Atrial Fibrillation Decision-Support Tool (AFDST) vs. AFDST with addition of best practice advisory (BPA) and semi-automat...
Eligibility Criteria
Inclusion
- • Diagnosis of non-valvular atrial fibrillation or atrial flutter (I48.x)
Exclusion
- • Diagnosis of valvular heart disease (mitral valve disease (I05.x), aortic valve disease (I06.x), mitral and aortic valve disease (I08.x)), presence of prosthetic heart valve (Z95.2), or presence of xenogenic heart valve (Z95.3), or presence of other heart valve replacement (Z95.4).
Key Trial Info
Start Date :
November 18 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2023
Estimated Enrollment :
608 Patients enrolled
Trial Details
Trial ID
NCT04099485
Start Date
November 18 2020
End Date
February 28 2023
Last Update
May 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Cincinnati Health System
Cincinnati, Ohio, United States, 45257